Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DL Alpha Aminocaprolactam. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102093292A reveals a safe two-step route for DL-alpha-aminocaprolactam, eliminating toxic azides for reliable pharmaceutical intermediates manufacturing.
Eliminate NaN3 hazards in DL-α-aminocaprolactam production. This two-step method offers high yields (81-85%) and simplified purification, reducing supply chain risks for lysine manufacturing.